Connecting TDP-43 Pathology with Neuropathy

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Transactive response DNA-binding protein 43 kDa (TDP-43) is implicated in neurodegenerative diseases.
• TDP-43 aggregates are hallmarks of conditions like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• Mutations in the TARDBP gene encoding TDP-43 cause familial ALS and FTD.

Purpose of the Study:

• To review the established and emerging roles of TDP-43 in the nervous system.
• To explore how TDP-43 dysfunction impacts RNA homeostasis and contributes to neural degeneration.
• To highlight the therapeutic potential of targeting TDP-43 for neurological disorders.

Main Methods:

• Literature review of established and emerging research on TDP-43.
• Analysis of TDP-43's role in RNA processing and homeostasis.
• Examination of the link between TDP-43 dysfunction and specific neuropathies, such as STMN2 splicing alterations.

Main Results:

• TDP-43 dysfunction significantly impairs RNA homeostasis in the nervous system.
• Aberrant splicing of STMN2 is a key mechanism linking TDP-43 proteinopathies to neuropathy.
• Dysfunctional TDP-43 contributes to the pathogenesis of various neurodegenerative conditions.

Conclusions:

• A comprehensive understanding of TDP-43's function is crucial for developing novel therapeutic strategies.
• Targeting TDP-43 offers a promising avenue for treating a range of neurological disorders.
• Further research into TDP-43's molecular mechanisms may unlock new treatment possibilities for patients.